Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Cell & Gene Therapy Manufacturing Services Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
The global market for cell & gene therapy manufacturing services is experiencing a remarkable growth surge, poised for substantial expansion at a compounded annual growth rate (CAGR) of 16.6%, reaching an impressive $15.77 billion by 2028. A newly published research report available on our website meticulously analyzes this dynamic market, unravelling the key drivers, trends, and opportunities that are shaping its trajectory.
This comprehensive research study delves into the intricacies of cell and gene therapies, which are at the forefront of revolutionizing treatment approaches for a range of conditions, including the rapidly growing incidence of cancer. Innovative medical solutions that cater to the unique genetic makeup of individuals are fueling a move towards personalized medicine, pushing the boundaries of healthcare and biotechnology.
The report pays special attention to the technological innovations catalyzing efficiency in the manufacturing processes of cell & gene therapies. Notable breakthroughs, such as advanced viral vector platforms, are significantly enhancing the scalability and speed of development in this field.
Key Highlights and Trends:
- North America leads the market in 2023, while Asia-Pacific emerges as the fastest-growing region during the forecast period
- Advances in personalized medicine, heightened R&D investment, and strategic industry collaborations are major growth drivers
- Technological innovations and the integration of automation and robotics are transforming manufacturing processes
- Escalation in chronic diseases, particularly cancer, underlines the urgent need for effective cell & gene therapy treatments
The report provides an exhaustive analysis of various segments within the market and their vast applications across diverse indications such as oncology, cardiology, and orthopedic diseases among others.
We witness strategic partnerships reshaping the industry landscape, such as recent collaborations to develop the next-generation of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer treatment.
With an emphasis on the market's competitive dynamics, the report profiles major players contributing to the advancements in cell & gene therapy manufacturing. Their efforts are pivotal in catering to the increased demands for improved medical therapies and shaping a more efficient and responsive healthcare environment.
The intricate details outlined in the report offer invaluable insights into the cell and gene therapy manufacturing services market, equipping stakeholders with the information needed to navigate this complex yet promising industry landscape. It represents critical reading for anyone looking to understand the full scope of market challenges and prospects.
A selection of companies mentioned in this report includes
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Charles River Laboratories International Inc.
- Lonza Group AG
- Catalent Inc.
- WuXi AppTec
- Takara Bio Inc.
- Nikon Corporation
- Fujifilm Holdings Corporation
- F. Hoffmann-La Roche Ltd
- Oxford Biomedica plc
- CGT Catapult
- bluebird bio Inc.
- Boehringer Ingelheim International GmbH
- Innovative Cellular Therapeutics Co. Ltd.
- Samsung Biologics Co. Ltd.
- Novartis International AG
- Pfizer Inc.
- Brammer Bio
- AGC Biologics
- Cognate BioServices Inc.
- Paragon Bioservices Inc.
- Merck KGaA operating as MilliporeSigma
- Sarepta Therapeutics Inc.
- Spark Therapeutics Inc.
- Orchard Therapeutics plc
- Precision BioSciences Inc.
- PCT a Hitachi Group Company
- Aldevron LLC
- BioNTech SE
For more information about this report visit https://www.researchandmarkets.com/r/xa15q7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
